NCT05517317View on ClinicalTrials.gov

Autologous BMNC Infusion for Liver Cirrhosis in Children With BA

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

May 30, 2022

Study Completion Date

May 30, 2022

Conditions
Biliary Atresia
Interventions
COMBINATION_PRODUCT

Autologous BMMC transplantation

One administration of autologous bone marrow mononuclear cells via the hepatic artery

Trial Locations (1)

100000

Vinmec Research Institute of Stem Cell and Gene Technology, Hanoi

All Listed Sponsors
lead

Vinmec Research Institute of Stem Cell and Gene Technology

OTHER

NCT05517317 - Autologous BMNC Infusion for Liver Cirrhosis in Children With BA | Biotech Hunter | Biotech Hunter